Federal Agency · Centers for Disease Control - NCCDPHP
Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations
Last updated: September 6, 2026
Posted September 3, 2026
Funding
$0
Closes
February 5, 2027
NAICS
621
Since 1990, CDC's Division of Cancer Prevention and Control (DCPC) has been working with national organizations, state, territory, freely associated state, and tribal health agencies, and other key groups to develop, implement, and promote effective strategies for preventing and controlling cancer. DCPC's overall mission is to work toward having all people free of cancer while improving health outcomes through prevention, screening, and ongoing care for cancer survivors. DCPC supports comprehensive cancer control, a philosophical approach that brings together partners and other organizations to collectively address a community's cancer burden in a much more impactful way than any one organization could accomplish alone. This NOFO will fund eligible applicants to facilitate collaborative planning and implementation of evidence-based cancer surveillance, prevention, and control strategies in communities that improve the provision of clinical preventive services, and cancer survivorship. Ultimately, a successful implementation of the work described in this NOFO will demonstrate that by the three programs working together through partnerships, coordination of resources and efforts, consistent communication, and community involvement, we will come that much closer to the division's mission of "All People Free of Cancer." This program takes a comprehensive, coordinated approach to achieve these goals. It supports breast and cervical cancer screening and diagnostic services, cancer control plan implementation by coalitions, and surveillance programs to monitor and report cancer burden.These goals will be accomplished by funding three national programs:Program 1: National Breast and Cervical Cancer Early Detection Program (NBCCEDP) supports clinical services for women with low incomes who do not have adequate insurance and implementation of evidence-based interventions in the clinics that serve them. Component A: Supports breast and cervical cancer screening and diagnostic follow-up for women with low incomes who do not have adequate insurance. Component B: (Optional) Supports implementation of evidence-based interventions (EBIs) shown to increase breast and cervical cancer screening.Program 2: National Comprehensive Cancer Control Program (NCCCP) supports cancer coalition efforts that use their individual and collective resources to plan and implement evidence-based strategies as described in jurisdiction-wide cancer plans.Program 3: National Program of Cancer Registries (NPCR) supports the implementation of a population-based central cancer registry program.
Eligibility
- Funded by CDC
Award details
Award range: $0. Applications close on February 5, 2027 (151 days remaining).
Categories
Not categorized
Sign up at GrantRegister to see if this grant matches your organization.
Match my organization →View application on Grants.gov →·Source: Grants.gov·Last seen Sep 6, 2026
Similar grants
- Applied Drug Policy Research ExperiencesOffice of National Drug Control Policy · closes September 6, 2026
- Building Lasting U.S.-Chad Partnerships to Promote American ExcellenceU.S. Mission to Chad · closes September 6, 2026
- Alcohol Health Services Research (R01 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)National Institutes of Health · closes September 7, 2026
- Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)National Institutes of Health · closes September 7, 2026
- Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)National Institutes of Health · closes September 7, 2026
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)National Institutes of Health · closes September 7, 2026
